Financhill
Buy
56

IOSP Quote, Financials, Valuation and Earnings

Last price:
$78.11
Seasonality move :
4.29%
Day range:
$77.91 - $78.55
52-week range:
$70.10 - $117.08
Dividend yield:
2.19%
P/E ratio:
98.17x
P/S ratio:
1.09x
P/B ratio:
1.49x
Volume:
45.2K
Avg. volume:
293K
1-year change:
-29.82%
Market cap:
$1.9B
Revenue:
$1.8B
EPS (TTM):
-$0.06

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IOSP
Innospec, Inc.
$437.5M $1.06 -1.27% -20.34% $99.33
BCPC
Balchem Corp.
$258.3M $1.31 8.16% 24.54% $191.00
CC
The Chemours Co.
$1.5B $0.24 -4.68% 17.16% $15.56
PZG
Paramount Gold Nevada Corp.
-- -$0.02 -- -50% $1.70
XPL
Solitario Resources Corp.
-- -$0.01 -- -64.16% $1.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IOSP
Innospec, Inc.
$78.12 $99.33 $1.9B 98.17x $0.87 2.19% 1.09x
BCPC
Balchem Corp.
$157.14 $191.00 $5.1B 34.40x $0.96 0.61% 5.06x
CC
The Chemours Co.
$12.01 $15.56 $1.8B 66.47x $0.09 4.27% 0.31x
PZG
Paramount Gold Nevada Corp.
$1.18 $1.70 $92.5M -- $0.00 0% --
XPL
Solitario Resources Corp.
$0.64 $1.50 $58.1M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IOSP
Innospec, Inc.
3.64% 0.502 2.56% 1.77x
BCPC
Balchem Corp.
11.7% 0.403 3.54% 1.54x
CC
The Chemours Co.
93.68% 1.744 185.82% 0.76x
PZG
Paramount Gold Nevada Corp.
27.01% 2.031 12.18% 1.08x
XPL
Solitario Resources Corp.
0.07% 0.780 0.03% 17.12x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IOSP
Innospec, Inc.
$116.7M $31.1M -0.09% -0.1% 7.04% $17.2M
BCPC
Balchem Corp.
$95.5M $54.9M 10.45% 12.23% 20.52% $50.7M
CC
The Chemours Co.
$231M $98M -6.85% -69.66% 6.56% $105M
PZG
Paramount Gold Nevada Corp.
-$95.7K -$1.5M -25.69% -34.36% -- -$1.1M
XPL
Solitario Resources Corp.
-$18K -$2M -20.56% -20.59% -- -$1.7M

Innospec, Inc. vs. Competitors

  • Which has Higher Returns IOSP or BCPC?

    Balchem Corp. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of 15.06%. Innospec, Inc.'s return on equity of -0.1% beat Balchem Corp.'s return on equity of 12.23%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec, Inc.
    26.41% $0.52 $1.4B
    BCPC
    Balchem Corp.
    35.68% $1.24 $1.5B
  • What do Analysts Say About IOSP or BCPC?

    Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 27.16%. On the other hand Balchem Corp. has an analysts' consensus of $191.00 which suggests that it could grow by 21.94%. Given that Innospec, Inc. has higher upside potential than Balchem Corp., analysts believe Innospec, Inc. is more attractive than Balchem Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec, Inc.
    2 0 0
    BCPC
    Balchem Corp.
    1 1 0
  • Is IOSP or BCPC More Risky?

    Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison Balchem Corp. has a beta of 0.992, suggesting its less volatile than the S&P 500 by 0.809%.

  • Which is a Better Dividend Stock IOSP or BCPC?

    Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.19%. Balchem Corp. offers a yield of 0.61% to investors and pays a quarterly dividend of $0.96 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. Balchem Corp. pays out 22.16% of its earnings as a dividend. Balchem Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec, Inc.'s is not.

  • Which has Better Financial Ratios IOSP or BCPC?

    Innospec, Inc. quarterly revenues are $441.9M, which are larger than Balchem Corp. quarterly revenues of $267.6M. Innospec, Inc.'s net income of $12.9M is lower than Balchem Corp.'s net income of $40.3M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while Balchem Corp.'s PE ratio is 34.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.09x versus 5.06x for Balchem Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec, Inc.
    1.09x 98.17x $441.9M $12.9M
    BCPC
    Balchem Corp.
    5.06x 34.40x $267.6M $40.3M
  • Which has Higher Returns IOSP or CC?

    The Chemours Co. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of 4.01%. Innospec, Inc.'s return on equity of -0.1% beat The Chemours Co.'s return on equity of -69.66%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec, Inc.
    26.41% $0.52 $1.4B
    CC
    The Chemours Co.
    15.45% $0.40 $4.7B
  • What do Analysts Say About IOSP or CC?

    Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 27.16%. On the other hand The Chemours Co. has an analysts' consensus of $15.56 which suggests that it could grow by 32.5%. Given that The Chemours Co. has higher upside potential than Innospec, Inc., analysts believe The Chemours Co. is more attractive than Innospec, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec, Inc.
    2 0 0
    CC
    The Chemours Co.
    4 4 0
  • Is IOSP or CC More Risky?

    Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison The Chemours Co. has a beta of 1.593, suggesting its more volatile than the S&P 500 by 59.275%.

  • Which is a Better Dividend Stock IOSP or CC?

    Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.19%. The Chemours Co. offers a yield of 4.27% to investors and pays a quarterly dividend of $0.09 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. The Chemours Co. pays out 174.61% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or CC?

    Innospec, Inc. quarterly revenues are $441.9M, which are smaller than The Chemours Co. quarterly revenues of $1.5B. Innospec, Inc.'s net income of $12.9M is lower than The Chemours Co.'s net income of $60M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while The Chemours Co.'s PE ratio is 66.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.09x versus 0.31x for The Chemours Co.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec, Inc.
    1.09x 98.17x $441.9M $12.9M
    CC
    The Chemours Co.
    0.31x 66.47x $1.5B $60M
  • Which has Higher Returns IOSP or PZG?

    Paramount Gold Nevada Corp. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of --. Innospec, Inc.'s return on equity of -0.1% beat Paramount Gold Nevada Corp.'s return on equity of -34.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec, Inc.
    26.41% $0.52 $1.4B
    PZG
    Paramount Gold Nevada Corp.
    -- -$0.06 $43.2M
  • What do Analysts Say About IOSP or PZG?

    Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 27.16%. On the other hand Paramount Gold Nevada Corp. has an analysts' consensus of $1.70 which suggests that it could grow by 44.07%. Given that Paramount Gold Nevada Corp. has higher upside potential than Innospec, Inc., analysts believe Paramount Gold Nevada Corp. is more attractive than Innospec, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec, Inc.
    2 0 0
    PZG
    Paramount Gold Nevada Corp.
    1 0 0
  • Is IOSP or PZG More Risky?

    Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison Paramount Gold Nevada Corp. has a beta of 1.319, suggesting its more volatile than the S&P 500 by 31.91%.

  • Which is a Better Dividend Stock IOSP or PZG?

    Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.19%. Paramount Gold Nevada Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. Paramount Gold Nevada Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or PZG?

    Innospec, Inc. quarterly revenues are $441.9M, which are larger than Paramount Gold Nevada Corp. quarterly revenues of --. Innospec, Inc.'s net income of $12.9M is higher than Paramount Gold Nevada Corp.'s net income of -$4.3M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while Paramount Gold Nevada Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.09x versus -- for Paramount Gold Nevada Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec, Inc.
    1.09x 98.17x $441.9M $12.9M
    PZG
    Paramount Gold Nevada Corp.
    -- -- -- -$4.3M
  • Which has Higher Returns IOSP or XPL?

    Solitario Resources Corp. has a net margin of 2.92% compared to Innospec, Inc.'s net margin of --. Innospec, Inc.'s return on equity of -0.1% beat Solitario Resources Corp.'s return on equity of -20.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec, Inc.
    26.41% $0.52 $1.4B
    XPL
    Solitario Resources Corp.
    -- -$0.02 $24.8M
  • What do Analysts Say About IOSP or XPL?

    Innospec, Inc. has a consensus price target of $99.33, signalling upside risk potential of 27.16%. On the other hand Solitario Resources Corp. has an analysts' consensus of $1.50 which suggests that it could grow by 134.56%. Given that Solitario Resources Corp. has higher upside potential than Innospec, Inc., analysts believe Solitario Resources Corp. is more attractive than Innospec, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec, Inc.
    2 0 0
    XPL
    Solitario Resources Corp.
    2 0 0
  • Is IOSP or XPL More Risky?

    Innospec, Inc. has a beta of 0.931, which suggesting that the stock is 6.907% less volatile than S&P 500. In comparison Solitario Resources Corp. has a beta of 0.440, suggesting its less volatile than the S&P 500 by 55.966%.

  • Which is a Better Dividend Stock IOSP or XPL?

    Innospec, Inc. has a quarterly dividend of $0.87 per share corresponding to a yield of 2.19%. Solitario Resources Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec, Inc. pays 109.37% of its earnings as a dividend. Solitario Resources Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IOSP or XPL?

    Innospec, Inc. quarterly revenues are $441.9M, which are larger than Solitario Resources Corp. quarterly revenues of --. Innospec, Inc.'s net income of $12.9M is higher than Solitario Resources Corp.'s net income of -$1.9M. Notably, Innospec, Inc.'s price-to-earnings ratio is 98.17x while Solitario Resources Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec, Inc. is 1.09x versus -- for Solitario Resources Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec, Inc.
    1.09x 98.17x $441.9M $12.9M
    XPL
    Solitario Resources Corp.
    -- -- -- -$1.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock